• Management of Adverse Effects Associated With Novel Therapies

  • Jun 9 2022
  • Duración: 13 m
  • Podcast

Management of Adverse Effects Associated With Novel Therapies  Por  arte de portada

Management of Adverse Effects Associated With Novel Therapies

  • Resumen

  • Management of relapsed/refractory LBCLs remains a substantial and persistent clinical challenge, including optimal treatment sequencing, therapy evaluation and patient selection, and toxicity management.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Management of Adverse Effects Associated With Novel Therapies

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.